Alchemab Therapeutics vs Pathos AI
Which Drug Discovery AI tool is better in 2026?
Alchemab Therapeutics
Pathos AI
Side-by-side
Pathos AI is the more established option (raised $467M); pricing is comparable on both sides.
| Metric | Alchemab Therapeutics | Pathos AI |
|---|---|---|
| Taglinei | — | — |
| Foundedi | — | 2022🏆 |
| HQi | — | — |
| Employeesi | 11-50 | 11-50 |
| Neuron scorei | 66 | 72🏆 |
| Total fundingi | $32M | $467M🏆 |
| Latest roundi | Series A | Series D · May 2025 |
| Valuationi | — | $1.6B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✓ | ✓ |
| Free triali | ✓ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Free | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Alchemab Therapeutics and Pathos AI.
| Capability | Alchemab Therapeutics | Pathos AI |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✓ | ✓ |
| Free trial | ✓ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Alchemab Therapeutics
- Strong in Drug Discovery
🔵 Strengths of Pathos AI
- Has raised more capital ($467M vs $32M)
- Higher Neuron score (72 vs 66)
- Newer company (2022)
Which should you choose?
Choose Pathos AI if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Pathos AI if you want the most established option — it has raised $467M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Alchemab Therapeutics vs Pathos AI — which is better?
It depends on your priority. Alchemab Therapeutics is the leaner option; Pathos AI has broader feature depth. See the side-by-side table above.
Is Alchemab Therapeutics cheaper than Pathos AI?
No — Pathos AI's cheapest paid plan is Free, while Alchemab Therapeutics's is Free.
Do Alchemab Therapeutics and Pathos AI offer free plans?
Alchemab Therapeutics: Yes, has a free plan. Pathos AI: Yes, has a free plan.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.